Back to Research

Organization profile

metaLead Therapeutics

[Confidence Level: High] metaLead Therapeutics is a Swiss biotechnology organization developing a platform of short, heavily modified peptides designed to selectively capture and remove toxic metal ions while preserving essential ones.11

Basel, SwitzerlandFounded 2023

Overview

[Confidence Level: High] metaLead Therapeutics is a Swiss biotechnology organization developing a platform of short, heavily modified peptides designed to selectively capture and remove toxic metal ions while preserving essential ones.11

Unlock the full profileGet the complete company dossier

This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.

Desktop only

Research is currently available on desktop only.

The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.